Literature DB >> 29248000

Autophagy limits activation of the inflammasomes.

Michihiro Takahama1, Shizuo Akira2,3, Tatsuya Saitoh1.   

Abstract

Inflammasomes are multiprotein complexes that control the maturation and production of interleukin-1 family members and play crucial roles in host defense against pathogens. However, dysregulated activation of inflammasomes is associated with intense inflammation, leading to the development of inflammatory diseases. Therefore, inflammasomes must be activated at a proper strength to protect against infection and avoid tissue damage. Recent studies have highlighted the cross-talk between inflammasome activation and autophagy, the cellular machinery associated with the degradation of intracellular components and maintenance of cellular homeostasis. Notably, deficiencies in autophagy-related proteins induce the aberrant activation of inflammasomes, causing severe tissue damage. In contrast, autophagy inducers ameliorate symptoms of inflammasome-related diseases. In this review, we discuss recent advances in the involvement of autophagy in regulating inflammasomes activation and in the development of inflammatory diseases.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cytokines; endotoxin shock; inflammation; inflammatory bowel disease; signaling proteins; toll-like receptors/pattern recognition receptors

Mesh:

Substances:

Year:  2018        PMID: 29248000     DOI: 10.1111/imr.12613

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  48 in total

1.  Bacterial Type I CRISPR-Cas systems influence inflammasome activation in mammalian host by promoting autophagy.

Authors:  Qun Wu; Biao Wang; Chuanmin Zhou; Ping Lin; Shugang Qin; Pan Gao; Zhihan Wang; Zhenwei Xia; Min Wu
Journal:  Immunology       Date:  2019-09-17       Impact factor: 7.397

Review 2.  An evolutionary perspective on immunometabolism.

Authors:  Andrew Wang; Harding H Luan; Ruslan Medzhitov
Journal:  Science       Date:  2019-01-11       Impact factor: 47.728

3.  Methylomic correlates of autophagy activity in cystic fibrosis.

Authors:  Kyle Caution; Alexander Pan; Kathrin Krause; Asmaa Badr; Kaitlin Hamilton; Anup Vaidya; Hawin Gosu; Kylene Daily; Shady Estfanous; Mikhail A Gavrilin; Mark E Drew; Estelle Cormet-Boyaka; Xi Chen; David E Frankhouser; Ralf Bundschuh; Pearlly Yan; Duaa Dakhlallah; Amal O Amer
Journal:  J Cyst Fibros       Date:  2019-02-06       Impact factor: 5.482

4.  Podocytes and autophagy: a potential therapeutic target in lupus nephritis.

Authors:  Xu-Jie Zhou; Daniel J Klionsky; Hong Zhang
Journal:  Autophagy       Date:  2019-02-17       Impact factor: 16.016

Review 5.  The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.

Authors:  Keesha M Matz; R Marena Guzman; Alan G Goodman
Journal:  Int Rev Cell Mol Biol       Date:  2018-09-25       Impact factor: 6.813

Review 6.  Focus on the Multimodal Role of Autophagy in Rheumatoid Arthritis.

Authors:  Swati Chadha; Tapan Behl; Simona Bungau; Arun Kumar; Rajwinder Kaur; Thangaval Venkatachalam; Amit Gupta; Mimansa Kandhwal; Deepak Chandel
Journal:  Inflammation       Date:  2020-09-21       Impact factor: 4.092

Review 7.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

Review 8.  Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

9.  SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect.

Authors:  Bin Zhang; Hangang Chen; Junjie Ouyang; Yangli Xie; Liang Chen; Qiaoyan Tan; Xiaolan Du; Nan Su; Zhenhong Ni; Lin Chen
Journal:  Autophagy       Date:  2019-09-22       Impact factor: 16.016

10.  Δ9-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture.

Authors:  Michael D Rizzo; Robert B Crawford; Anthony Bach; Sera Sermet; Andrea Amalfitano; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2019-08-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.